New respiratory therapies in cystic fibrosis.
作者信息
Stableforth D E
机构信息
Adult Cystic Fibrosis Unit, Birmingham Heartlands Hospital.
出版信息
J R Soc Med. 1994;87 Suppl 21(Suppl 21):11-6.
Abstract
摘要
相似文献
1
New respiratory therapies in cystic fibrosis.囊性纤维化的新型呼吸治疗方法。
J R Soc Med. 1994;87 Suppl 21(Suppl 21):11-6.
2
Emerging therapies for cystic fibrosis lung disease.囊性纤维化肺病的新兴疗法。
Chest. 1999 Apr;115(4):1120-6. doi: 10.1378/chest.115.4.1120.
3
Clinical management of pulmonary disease in cystic fibrosis.囊性纤维化肺病的临床管理
Lancet. 1993 Apr 24;341(8852):1070-4. doi: 10.1016/0140-6736(93)92423-q.
4
Newer therapies for cystic fibrosis.囊性纤维化的新型疗法。
Paediatr Respir Rev. 2000 Jun;1(2):107-13. doi: 10.1053/prrv.2000.0031.
5
New therapies for cystic fibrosis.囊性纤维化的新疗法。
J La State Med Soc. 1998 Dec;150(12):629-37.
6
Treatment strategies for cystic fibrosis: what's in the pipeline?囊性纤维化的治疗策略：未来有哪些进展？
Expert Opin Pharmacother. 2009 May;10(7):1191-202. doi: 10.1517/14656560902928896.
7
Recent advances in the treatment of cystic fibrosis.囊性纤维化治疗的最新进展。
Pediatr Clin North Am. 1994 Jun;41(3):431-51. doi: 10.1016/s0031-3955(16)38764-8.
8
[Current treatment of cystic fibrosis].[囊性纤维化的当前治疗方法]
Rev Clin Esp. 1999 Aug;199(8):541-5.
9
State of progress in treating cystic fibrosis respiratory disease.囊性纤维化呼吸道疾病治疗进展状况。
BMC Med. 2012 Aug 10;10:88. doi: 10.1186/1741-7015-10-88.
10
Management of pulmonary disease in patients with cystic fibrosis.囊性纤维化患者肺部疾病的管理
N Engl J Med. 1996 Jul 18;335(3):179-88. doi: 10.1056/NEJM199607183350307.
本文引用的文献
1
Liquefaction of viscous purulent exudates by deoxyribonuclease.脱氧核糖核酸酶对粘性脓性渗出物的液化作用。
Lancet. 1950 Dec 9;2(6641):739-42. doi: 10.1016/s0140-6736(50)91676-x.
2
RENAL HETEROTRANSPLANTATION FROM BABOON TO MAN: EXPERIENCE WITH 6 CASES.从狒狒到人类的肾异种移植：6例经验
Transplantation. 1964 Nov;2:752-76. doi: 10.1097/00007890-196411000-00009.
3
RENAL HETEROTRANSPLANTATION IN MAN.人类肾异体移植
Ann Surg. 1964 Sep;160(3):384-410. doi: 10.1097/00000658-196409000-00006.
4
STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY.肺分泌物研究。I. 囊性纤维化、支气管扩张症和喉切除患者肺分泌物的整体化学成分
Am Rev Respir Dis. 1963 Aug;88:199-204. doi: 10.1164/arrd.1963.88.2.199.
5
Deoxyribonuclease in the treatment of purulent bronchitis.脱氧核糖核酸酶治疗化脓性支气管炎
Thorax. 1953 Dec;8(4):295-300. doi: 10.1136/thx.8.4.295.
6
Organs from animals.来自动物的器官。
BMJ. 1993 Sep 11;307(6905):637-8. doi: 10.1136/bmj.307.6905.637.
7
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.雾化吸入重组人脱氧核糖核酸酶I短期治疗稳定期成人囊性纤维化的疗效和安全性。
Lancet. 1993 Jul 24;342(8865):199-202. doi: 10.1016/0140-6736(93)92297-7.
8
Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy.通过基因疗法纠正囊性纤维化转基因小鼠的离子转运缺陷。
Nature. 1993 Mar 18;362(6417):250-5. doi: 10.1038/362250a0.
9
Amiloride: a molecular probe of sodium transport in tissues and cells.氨氯地平：组织和细胞中钠转运的分子探针。
Am J Physiol. 1982 Mar;242(3):C131-45. doi: 10.1152/ajpcell.1982.242.3.C131.
10
Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy.多粘菌素甲磺酸钠的不良反应。317个疗程中的表现及具体反应率
Ann Intern Med. 1970 Jun;72(6):857-68. doi: 10.7326/0003-4819-72-6-857.
Zotero 插件